vs
Mama's Creations, Inc.（MAMA）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Mama's Creations, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.3倍（$47.3M vs $35.5M），Mama's Creations, Inc.净利率更高（1.1% vs -304.2%，领先305.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 50.0%），Mama's Creations, Inc.自由现金流更多（$3.7M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 33.0%）
Mama's Creations是一家美国食品制造企业，主要生产冷藏即食、加热即食类食品，涵盖意式肉丸、香肠、意面餐食等预制菜品，产品主要供应美国本土的零售商超、大众零售商及餐饮服务合作伙伴，主打便捷高品质的家常风味食品。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
MAMA vs RXRX — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.3M | $35.5M |
| 净利润 | $540.0K | $-108.1M |
| 毛利率 | 23.6% | 59.8% |
| 营业利润率 | 1.7% | -304.8% |
| 净利率 | 1.1% | -304.2% |
| 营收同比 | 50.0% | 681.7% |
| 净利润同比 | 31.7% | 39.6% |
| 每股收益（稀释后） | $0.01 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $47.3M | $35.5M | ||
| Q3 25 | $35.2M | $5.2M | ||
| Q2 25 | $35.3M | $19.2M | ||
| Q1 25 | $33.6M | $14.7M | ||
| Q4 24 | $31.5M | $4.5M | ||
| Q3 24 | $28.4M | $26.1M | ||
| Q2 24 | $29.8M | $14.4M | ||
| Q1 24 | $26.7M | $13.8M |
| Q4 25 | $540.0K | $-108.1M | ||
| Q3 25 | $1.3M | $-162.3M | ||
| Q2 25 | $1.2M | $-171.9M | ||
| Q1 25 | $1.6M | $-202.5M | ||
| Q4 24 | $410.0K | $-178.9M | ||
| Q3 24 | $1.1M | $-95.8M | ||
| Q2 24 | $553.0K | $-97.5M | ||
| Q1 24 | $1.4M | $-91.4M |
| Q4 25 | 23.6% | 59.8% | ||
| Q3 25 | 24.9% | -183.8% | ||
| Q2 25 | 26.1% | -4.9% | ||
| Q1 25 | 27.0% | -48.0% | ||
| Q4 24 | 22.6% | -181.4% | ||
| Q3 24 | 24.2% | 53.7% | ||
| Q2 24 | 25.0% | 36.2% | ||
| Q1 24 | 29.3% | 19.1% |
| Q4 25 | 1.7% | -304.8% | ||
| Q3 25 | 4.8% | -3327.6% | ||
| Q2 25 | 4.5% | -916.8% | ||
| Q1 25 | 5.7% | -1297.9% | ||
| Q4 24 | 1.8% | -4042.4% | ||
| Q3 24 | 5.7% | -377.1% | ||
| Q2 24 | 2.6% | -697.4% | ||
| Q1 24 | 7.4% | -698.4% |
| Q4 25 | 1.1% | -304.2% | ||
| Q3 25 | 3.6% | -3135.3% | ||
| Q2 25 | 3.5% | -894.2% | ||
| Q1 25 | 4.8% | -1373.3% | ||
| Q4 24 | 1.3% | -3935.5% | ||
| Q3 24 | 4.0% | -367.5% | ||
| Q2 24 | 1.9% | -676.6% | ||
| Q1 24 | 5.3% | -662.4% |
| Q4 25 | $0.01 | $-0.17 | ||
| Q3 25 | $0.03 | $-0.36 | ||
| Q2 25 | $0.03 | $-0.41 | ||
| Q1 25 | $0.04 | $-0.50 | ||
| Q4 24 | $0.01 | $-0.56 | ||
| Q3 24 | $0.03 | $-0.34 | ||
| Q2 24 | $0.01 | $-0.40 | ||
| Q1 24 | $0.03 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.1M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $49.6M | $1.1B |
| 总资产 | $84.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $18.1M | $743.3M | ||
| Q3 25 | $9.4M | $659.8M | ||
| Q2 25 | $12.0M | $525.1M | ||
| Q1 25 | $7.2M | $500.5M | ||
| Q4 24 | $9.3M | $594.4M | ||
| Q3 24 | $7.4M | $427.6M | ||
| Q2 24 | $13.0M | $474.3M | ||
| Q1 24 | $11.0M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $49.6M | $1.1B | ||
| Q3 25 | $29.6M | $1.0B | ||
| Q2 25 | $26.4M | $919.1M | ||
| Q1 25 | $24.9M | $933.9M | ||
| Q4 24 | $23.0M | $1.0B | ||
| Q3 24 | $22.3M | $524.6M | ||
| Q2 24 | $20.3M | $584.4M | ||
| Q1 24 | $19.6M | $401.2M |
| Q4 25 | $84.0M | $1.5B | ||
| Q3 25 | $51.2M | $1.4B | ||
| Q2 25 | $52.7M | $1.3B | ||
| Q1 25 | $47.1M | $1.3B | ||
| Q4 24 | $47.9M | $1.4B | ||
| Q3 24 | $43.0M | $726.5M | ||
| Q2 24 | $47.2M | $775.9M | ||
| Q1 24 | $45.1M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.9M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $3.7M | $-47.3M |
| 自由现金流率自由现金流/营收 | 7.8% | -133.1% |
| 资本支出强度资本支出/营收 | 0.4% | 3.5% |
| 现金转化率经营现金流/净利润 | 7.16× | — |
| 过去12个月自由现金流最近4个季度 | $6.0M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $3.9M | $-46.1M | ||
| Q3 25 | $-1.7M | $-117.4M | ||
| Q2 25 | $6.0M | $-76.4M | ||
| Q1 25 | $-857.0K | $-132.0M | ||
| Q4 24 | $4.8M | $-115.4M | ||
| Q3 24 | $-2.4M | $-59.2M | ||
| Q2 24 | $3.6M | $-82.2M | ||
| Q1 24 | $6.7M | $-102.3M |
| Q4 25 | $3.7M | $-47.3M | ||
| Q3 25 | $-2.2M | $-117.6M | ||
| Q2 25 | $5.5M | $-79.6M | ||
| Q1 25 | $-930.0K | $-133.8M | ||
| Q4 24 | $2.5M | $-116.7M | ||
| Q3 24 | $-4.0M | $-63.8M | ||
| Q2 24 | $2.5M | $-83.4M | ||
| Q1 24 | $6.6M | $-109.0M |
| Q4 25 | 7.8% | -133.1% | ||
| Q3 25 | -6.2% | -2272.5% | ||
| Q2 25 | 15.5% | -413.9% | ||
| Q1 25 | -2.8% | -907.4% | ||
| Q4 24 | 8.0% | -2567.7% | ||
| Q3 24 | -14.1% | -244.6% | ||
| Q2 24 | 8.4% | -578.5% | ||
| Q1 24 | 24.8% | -789.9% |
| Q4 25 | 0.4% | 3.5% | ||
| Q3 25 | 1.5% | 4.7% | ||
| Q2 25 | 1.5% | 16.4% | ||
| Q1 25 | 0.2% | 12.4% | ||
| Q4 24 | 7.2% | 28.6% | ||
| Q3 24 | 5.6% | 17.5% | ||
| Q2 24 | 3.8% | 8.2% | ||
| Q1 24 | 0.4% | 48.2% |
| Q4 25 | 7.16× | — | ||
| Q3 25 | -1.31× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | -0.54× | — | ||
| Q4 24 | 11.71× | — | ||
| Q3 24 | -2.10× | — | ||
| Q2 24 | 6.58× | — | ||
| Q1 24 | 4.79× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
